Clinical Trial Update: Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies. [Phase 1]

View source ↗

Summary

This Phase I trial evaluated vorinostat in combination with docetaxel in patients with advanced and relapsed solid malignancies, including non-small cell lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Non-small Cell Lung Cancer
• Prostate Cancer
• Urothelial Carcinoma

Drugs mentioned

• Taxotere (docetaxel)
• Zolinza (vorinostat)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Non-Small-Cell Lung Carcinoma, Prostate Cancer | Phase 1 | Status: TERMINATED